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Abstract
We present an unusual transient pro-arrhythmic effect of ajmaline in a patient with resuscitated 
cardiac arrest and a left ventricular apical aneurysm. We discuss the clinical presentation and the 
possible  physio-pathological  explanation  for  this  new  pro-arrhythmic  effect  linked  to 
administration  of  intravenous  ajmaline.                                      
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Introduction
Brugada  syndrome  (BrS)  is  a  well-recognized  arrhythmogenic  disease  associated  with  an 
increased risk of sudden death related to ventricular tachyarrhythmias or ventricular fibrillation 
[1]. Sodium channel blockers drugs help clinicians to overcome one of the major characteristics 
of the disease,  the wide variation in the ECG pattern [2].  Among sodium channel blockers, 
ajmaline  has  been  demonstrated  to  be  the  one  with  highest  predictive  power  [3],  possibly 
because of its kinetics and strength of rate-dependent sodium channel blocking effects.            
A potential pro-arrhythmic effect of class I drugs has been reported [4]. Ajmaline challenge has 
been associated with lethal arrhythmias (polymorphic ventricular tachycardias and ventricular 
fibrillation),  even  in  patients  without  BrS  [5].                                     
 
Case  presentation                                         
We present the case of a 29 year-old man admitted to our hospital after a resuscitated cardiac 
arrest. His family history was negative for sudden cardiac death and channelopathies. His past 
medical  history  was  unremarkable:  the  patient  was  completely  asymptomatic  and  never 
complained of syncope or palpitations. Moreover, on clinical examination he didn't show any 
apparent  abnormality.  Electrocardiographic  findings  were  completely  normal.  An  exercise 
testing was clinically and electrically negative but rare isolated ventricular ectopic beats were 
documented during the test and in the recovery phase. For this reason the patient was planned 
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for a 24 hour Holter ECG registration. In the afternoon following the exercise testing, during a 
small effort, the patient experienced cardiac arrest. In the emergency room, he was found to be 
in ventricular fibrillation. Four DC shocks and iv adrenaline and cardio-pulmonary reanimation 
maneuvers obtained restoration of vital  signs and sinus rhythm. The ECG after resuscitation 
showed non-specific abnormalities of the repolarization in the infero-lateral leads (Figure 1A). 
The patient had full recovery from the neurological point of view. Cardiac magnetic resonance 
showed late-enhancement of the left ventricular apex associated with dyskinesia in the same 
region  and  of  the  antero-septal  portion  of  the  same  ventricle.  Coronary  angiography  and 
coronary  computed  tomography  didn't  reveal  any  coronary  artery  abnormalities  or  critical 
stenosis. Echocardiographic evaluation demonstrated a left ventricular ejection fraction of 40% 
and confirmed the cardiac magnetic resonance findings. Final diagnosis was resuscitated cardiac 
arrest  in  a  patient  with  left  ventricular  apical  aneurysm  of  unknown  origin  (ischemic  vs 
congenital). The patient finally underwent implantation of a defibrillator (ICD). 
Figure 1A: Baseline ECG showing aspecific repolarization abnormalities in the infero-lateral leads.
Figure 1B: ECG showing the beginning of  one  episode  of  accelerated  idioventricular  rhythm (AIVR).  Black 
arrows show P waves and isorhythmic AV dissociation. RR intervals shown on the top of the figure are expressed 
in ms.
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Figure 1C: ECG showing consecutively the end of the previous episode of AIVR and the beginning of another one. 
Black arrows show P waves and isorhythmic AV dissociation. RR intervals shown on the top of the figure are 
expressed  in  ms.                                    
At the end of the hospitalization, an ajmaline test was performed to exclude BrS. The ajmaline 
test  (1mg/kg  of  body  weight)  was  negative  for  BrS,  but,  after  0.7  mg/kg  injection  (49  mg 
complexively), we documented an accelerated idioventricular rhythm (AIVR) with a heart rate of 
95 bpm (Figure 1B). Diagnosis was confirmed after the evidence of AV dissociation and by a few 
fusion beats (Figure 1B and 1C). AIVR morphology was right bundle branch block (RBBB) and 
left anterior hemiblock (LAH). AIVR was preceded by a slight prolongation of the PQ interval 
(from 150 to 190 ms) and the QRS interval  (from 95 ms to 130 ms).  The arrhythmia ended 
spontaneously after  termination of ajmaline infusion.                                       
Discussion
To the best of our knowledge, our case report is the first to describe an AIVR during ajmaline test  
in  a  patient  with  a  resuscitated  cardiac  arrest  and  with  a  left  ventricular  apical  aneurysm.  
AIVR is defined as 3 or more successive wide QRS beats at a rate close to the baseline rhythm, 
with a maximal difference of 10-15% and with a heart rate between 100 and 120 bpm. AIVR is 
found to be the most common reperfusion arrhythmia in pre-thrombolytic and thrombolytic era: it 
is usually well tolerated [6-8] and no specific antiarrhythmic treatment is recommended apart 
from removing the suspected cause [9]. AIVR is believed to result from abnormal automaticity of 
the subendocardial Purkinje fibers owing to the washout phenomenon during infarct-related artery 
reperfusion  [10].  Other  investigators  suggested  triggered  activity  based  on  delayed 
afterdepolarizations as the underlying mechanism [11]. No association with ajmaline infusion has 
been  described  until  now in the  literature.                                               
Ajmaline test is a well-recognized diagnostic tool used to unmask the electrocardiographic pattern 
of BrS in patients with resuscitated cardiac arrest or syncopes and in genetic carriers belonging to 
families affected by this pathology [12]. Among the class I blockers, ajmaline is considered the 
most powerful to reveal the electrocardiographic alterations typical of BrS. Among the others, 
propafenone has been demonstrated to be a weaker agent, probably due to the associated block of 
Ito channels. Both therapeutic, toxic and proarrhythmic effects of all sodium channel blockers are 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 10 (10): 474-478 (2010)
Antonio Sorgente, Yoshinao Yazaki, Lucio Capulzini, Andrea Sarkozy,                          477  
Carlo  de  Asmundis,  Gian-Battista  Chierchia,  Stephan-Andreas  Müller-Burri,  Pedro 
Brugada, “Accelerated Idioventricular Rhythm During Ajmaline Test: a Case Report”
manifested on the ECG by a different degree of PR and QRS prolongation [13]. One large study 
using ajmaline to diagnose BrS [14] revealed a very low incidence of ventricular tachycardias 
(VT), around 1.3 %. All episodes of VT documented in this study were polymorphic, degenerated 
in  ventricular  fibrillation  and  occurred  in  patients  in  whom  drug  administration  after  the 
appearance of diagnostic Brugada-type ECG changes was not discontinued.                                  
Our case substantially differs from the latter for different reasons: 1) our patient had a negative 
ajmaline test; 2) echocardiography showed left apical ventricular aneurysm and 3) the arrhythmia 
related  to  the intravenous  administration of  ajmaline  was  an AIVR and not  a  VT.  Triggered 
activity  could  be  addressed  as  potential  electrophysiological  mechanism  leading  to  the  cited 
arrhythmia, seen the capability of ajmaline of inducing early afterdepolarizations in the Purkinje 
fibers [15]. Another hypothesis which could explain the AIVR is macro-reentry. Indeed, class I 
antiarrhythmic drugs have demonstrated to potentially cause monomorphic tachycardia linked to a 
shortening of activation wavelength below the physical length of a preformed reentry circuit [16]. 
We can hypothesize an equal contribution of this two mechanisms in the physio-pathology of the 
cited arrhythmia in  our  patient.  We think in fact  that  pathological  findings  evidenced  by the 
echocardiography  and  the  magnetic  resonance  together  with  the  prolongation  of  conduction 
associated with the block of Na channels could favor a slow reentry between the left anterior and 
the left posterior fascicle, determining the morphology of RBBB and LAH. We would exclude a 
toxic effect of the ajmaline, since the AIVR appeared already before reaching the maximal usual 
dose of 1 mg/kg, given to elicit  BrS ECG pattern.                                           
Ajmaline-related AIVR has never been reported. In this case report AIVR was probably favored 
by the presence of a left ventricular apical aneurysm. Our case report postulates that ajmaline 
induced AIVR increasing triggered activity of Purkinje fibers or decreasing the conduction on the 
two fascicles  of  the  left  bundle branch,  determining  a  slow macro-reentry  in  the  left  bundle 
branch.  Further  investigation  is  needed  to  define  the  mechanism  underlying  this  finding.
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